Physician profile
Anthony Bohan
NPI 1235131384
$3,977.28
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,270 · 2020: $268 · 2021: $840 · 2022: $720 · 2023: $675 · 2024: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $926.60 | 2019-2024 | Enbrel, Evenity, Prolia |
| Glaxosmithkline, LLC. | $530.43 | 2019-2024 | Benlysta |
| Lilly USA, LLC | $414.29 | 2019-2022 | |
| Janssen Biotech, INC. | $301.25 | 2019-2022 | |
| Horizon Therapeutics Plc | $247.37 | 2019 | |
| Pfizer INC. | $246.50 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $194.10 | 2019 | |
| Fresenius Kabi USA, LLC | $171.43 | 2023 | Idacio |
| Mallinckrodt Hospital Products INC. | $169.67 | 2020-2024 | Acthar |
| Radius Health, INC. | $126.99 | 2019-2023 | Tymlos |
| Janssen Scientific Affairs, LLC | $100.63 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $92.19 | 2021-2023 | Saphnelo |
| Abbvie INC. | $86.73 | 2019 | |
| Genzyme Corporation | $84.53 | 2019-2020 | |
| Celgene Corporation | $65.30 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $64.16 | 2022-2024 | Cimzia |
| Aurinia Pharma U.S., INC. | $55.45 | 2023 | Lupkynis |
| Ultragenyx Pharmaceutical INC. | $46.73 | 2021-2023 | Crysvita |
| Antares Pharma, INC. | $34.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Bohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.